Chau-Ting Yeh

Publication Activity (10 Years)

Years Active: 2017-2023
Publications (10 Years): 12

Top Topics

Radiofrequency Ablation

Hepatitis B Virus

Top Venues

Hepatology international

Journal of medical virology

Cell death & disease

Asia-Pacific journal of clinical oncology

This page only lists publications with an associated author ORCID identifier.

Publications

Yu-De Chu, Li-Chun Cheng, Siew-Na Lim, Ming-Wei Lai, Chau-Ting Yeh, Wey-Ran Lin
Aldolase B-driven lactagenesis and CEACAM6 activation promote cell renewal and chemoresistance in colorectal cancer through the Warburg effect. Cell death & disease 14 (10) (2023)
Wei-Ting Chen, Shi-Ming Lin, Wei-Chen Lee, Ting-Jung Wu, Chen-Chun Lin, Chien-Heng Shen, Ming-Ling Chang, Chih-Lang Lin, Chau-Ting Yeh
GALNT14 genotype-guided chemoembolization plus sorafenib therapy in hepatocellular carcinoma: a randomized trial. Hepatology international 16 (1) (2022)
Yu-De Chu, Tan-Chi Fan, Ming-Wei Lai, Chau-Ting Yeh
GALNT14-mediated O-glycosylation on PHB2 serine-161 enhances cell growth, migration and drug resistance by activating IGF1R cascade in hepatoma cells. Cell death & disease 13 (11) (2022)
Yang-Hsiang Lin, Meng-Han Wu, Yi-Chung Liu, Ping-Chiang Lyu, Chau-Ting Yeh, Kwang-Huei Lin
LINC01348 suppresses hepatocellular carcinoma metastasis through inhibition of SF3B3-mediated EZH2 pre-mRNA splicing. Oncogene 40 (28) (2021)
Chao-Wei Hsu, Charisse Yeh, Chau-Ting Yeh
Maintaining complete virological suppression by reduced doses of nucleos(t)ide analogue in patients with chronic hepatitis B. Journal of medical virology 91 (7) (2019)
Yu-Chiau Shyu, Ting-Shuo Huang, Cheng-Hung Chien, Chau-Ting Yeh, Chih-Lang Lin, Rong-Nan Chien
Diabetes poses a higher risk of hepatocellular carcinoma and mortality in patients with chronic hepatitis B: A population-based cohort study. Journal of viral hepatitis 26 (6) (2019)
Kuan-Chieh Lee, Chih-Lang Lin, Chao-Wei Hsu, Ming-Ling Chang, Yi-Cheng Chen, Wey-Ran Lin, Ming-Wei Lai, Kwang-Huei Lin, Mei Chao, Rong-Nan Chien, Chau-Ting Yeh
Decreasing seroprevalence of anti-hepatitis D virus antibodies in the antiviral era with inverse association with hepatitis B virus DNA, Taiwan, 2006 to 2019. Journal of medical virology 92 (1) (2019)
Chau-Ting Yeh, Christopher Sung-Huan Yeh, Yu-De Chu, Yang-Jen Chiang
Seroclearance of hepatitis B surface antigen following hepatitis E exacerbation on chronic hepatitis E and B dual infection in a renal transplant recipient: a case report. Journal of medical case reports 12 (1) (2018)
Ya-Hui Huang, Kwang-Huei Lin, Jau-Song Yu, Ting-Jung Wu, Wei-Chen Lee, Chuck C-K Chao, Tai-Long Pan, Chau-Ting Yeh
Targeting HSP60 by subcutaneous injections of jetPEI/HSP60-shRNA destabilizes cytoplasmic survivin and inhibits hepatocellular carcinoma growth. Molecular carcinogenesis 57 (9) (2018)
Yu-De Chu, Kwang-Huei Lin, Ya-Hui Huang, Chen-Chun Lin, Chien-Fu Hung, Ta-Sen Yeh, Wei-Chen Lee, Chau-Ting Yeh
A novel thyroid function index associated with opposite therapeutic outcomes in advanced hepatocellular carcinoma patients receiving chemotherapy or sorafenib. Asia-Pacific journal of clinical oncology 14 (5) (2018)
Ming-Wei Lai, Chao-Wei Hsu, Chih-Lang Lin, Rong-Nan Chien, Wey-Ran Lin, Chi-Sheng Chang, Kung-Hao Liang, Chau-Ting Yeh
Multiple doses of hepatitis B recombinant vaccine for chronic hepatitis B patients with low surface antigen levels: a pilot study. Hepatology international 12 (5) (2018)
Wey-Ran Lin, Chao-Wei Hsu, Christopher Sung-Huan Yeh, Yi-Cheng Chen, Ming-Ling Chang, Kung-Hao Liang, Chen-Chun Lin, Yu-De Chu, Chau-Ting Yeh
Combinations of single nucleotide polymorphisms WWOX-rs13338697, GALNT14-rs9679162 and rs6025211 effectively stratify outcomes of chemotherapy in advanced hepatocellular carcinoma. Asia-Pacific journal of clinical oncology 14 (2) (2017)